Search
for

    Sort by

    Research 241–270 of 1000+

    1. Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS) The Journal of Clinical Endocrinology and Metabolism · 2013 · 90 citations
    2. Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study The Journal of Clinical Endocrinology and Metabolism · 2013 · 75 citations
    3. Polycystic Ovary Syndrome: Diagnosis and Treatment The American Journal of Medicine · 2007 · 73 citations
    4. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial Gynecological Endocrinology · 2010 · 60 citations
    5. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome European journal of endocrinology · 2008 · 56 citations
    6. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study Reproductive Biology and Endocrinology · 2011 · 51 citations
    7. Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome European Journal of Endocrinology · 2011 · 50 citations
    8. Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference? Nutrition in Clinical Practice · 2008 · 48 citations
    9. Putative role for insulin resistance in depression risk in polycystic ovary syndrome Fertility and Sterility · 2015 · 46 citations
    10. Altered autonomic neural control of the cardiovascular system in patients with polycystic ovary syndrome International Journal of Cardiology · 2007 · 46 citations
    11. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. European journal of endocrinology · 2008 · 40 citations
    12. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess Fertility and Sterility · 2005 · 40 citations
    13. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare Reproductive Biology and Endocrinology · 2012 · 39 citations
    14. Pharmacotherapy of polycystic ovary syndrome - an update Fundamental & Clinical Pharmacology · 2011 · 34 citations
    15. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure Human Reproduction · 2017 · 32 citations
    16. Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome Endocrine Practice · 2001 · 32 citations
    17. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study Clinical Endocrinology · 2014 · 31 citations
    18. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome Clinical Endocrinology · 2019 · 30 citations
    19. Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet Frontiers in Endocrinology · 2019 · 28 citations
    20. Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS) Hormones · 2014 · 28 citations
    21. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? Journal of Reproductive Immunology · 2016 · 26 citations
    22. Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study Genetic Testing and Molecular Biomarkers · 2014 · 26 citations
    23. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent Fertility and Sterility · 2015 · 22 citations
    24. A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome Fertility and Sterility · 2000 · 20 citations
    25. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome Diabetes and Metabolic Syndrome: Clinical Research and Reviews · 2019 · 17 citations
    26. Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome Dermatology · 2008 · 17 citations
    27. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities Wiener Klinische Wochenschrift · 2015 · 16 citations
    28. Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome? Ginekologia Polska · 2022 · 15 citations
    29. Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome Iraqi Journal of Science · 2019 · 14 citations
    30. Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study Journal of Bone and Mineral Metabolism · 2017 · 14 citations